Alpa Laboratories peers

·Pharma & HealthChart ›

Companies like Alpa Laboratorieslatest year

Alpa LaboratoriesALPA · FY26 · this company
Market cap₹110
P/E7.78×
Sales growth+25.2%
ROE8.4%
Bal PharmaBALPHARMA · FY26
Open ›
Market cap₹137
P/E21.82×
Sales growth+34.5%
ROE7.9%
Krebs Biochemicals and IndustriesKREBSBIO · FY26
Open ›
Market cap₹128
P/E—
Sales growth+38.9%
ROE11.0%
Natural CapsulesNATCAPSUQ · FY26
Open ›
Market cap₹142
P/E—
Sales growth+7.8%
ROE−7.5%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ALPA₹52.20

Alpa Laboratories Limited

· Pharma & Health
₹ CrorePeersBALPHARMAKREBSBIONATCAPSUQVINEETLABNECLIFEAAREYDRUGSBIOFILCHEMMANGALAMMcap ₹110 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ALPA
FY26
BALPHARMA
FY26
KREBSBIO
FY26
NATCAPSUQ
FY26
Peer
Average
Valuation — at last close
P/E◆ 7.78×21.82×——21.82× -64%
P/B◆ 0.59×1.67×—0.64×1.15× -49%
EV/EBITDA-7.76×9.13×-64.63×◆ -169.48×-74.99× +90%
Market Cap₹110 Cr₹137 Cr₹128 Cr₹142 Cr₹135 Cr -19%
Growth
Revenue CAGR 3Y◆ 4.61%0.81%-23.07%—-11.13% +141%
Revenue CAGR 5Y1.64%◆ 4.46%-15.07%—-5.30% +131%
Net Income CAGR 3Y5.92%◆ 34.12%——34.12% -83%
Revenue YoY (latest Q)25.22%34.53%◆ 38.94%7.76%27.08% -7%
Net Income YoY (latest Q)-91.67%◆ 445.66%12.12%-2.93%151.62% -160%
Profitability
EBITDA Margin3.11%◆ 10.24%-22.97%-0.83%-4.52% +169%
Net Income Margin◆ 14.19%2.03%-71.35%-13.17%-27.50% +152%
Return on Common Equity8.39%7.87%◆ 10.96%-7.51%3.77% +122%
Return on Capital Employed0.66%◆ 17.17%-20.53%-6.12%-3.16% +121%
Return on Assets◆ 6.46%1.78%-10.19%-5.85%-4.75% +236%
Credit & Quality
Total Debt/Equity0.01×1.94×◆ -1.38×0.49×0.35× -97%
Interest Coverage◆ 4.64×1.24×-1.68×-1.71×-0.72× +747%
Scale — latest FY
Revenue / Total Income₹106 Cr₹312 Cr₹23.7 Cr₹187 Cr₹174 Cr -39%
Net Income₹15 Cr₹6.3 Cr−₹16.9 Cr−₹24.7 Cr−₹11.8 Cr +228%
Total Assets₹242 Cr₹376 Cr₹163 Cr₹424 Cr₹321 Cr -25%
EPS₹6.71₹3.95₹-7.85₹-23.84₹-9.25 +173%
Book Value per Share₹88.53₹51.65₹-75.49₹213.39₹63.18 +40%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.